This announcement is a separate document:
昭衍新药对会计师事务所2023年度履职情况评估报告
Zhaoyan Pharmaceutical's 2023 Performance Evaluation Report on Accounting Firms
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.